### ICB_Fehrenbacher

- **Read Paper:** [PMID: 26970723](https://pubmed.ncbi.nlm.nih.gov/26970723/)
- **Trial ID:** POPLAR / [NCT01903993](https://clinicaltrials.gov/study/NCT01903993)
- **Objective:** The trial evaluates the efficacy of atezolizumab versus chemotherapy in advanced non-small cell lung cancer (NSCLC), utilizing pre-treatment tumor transcriptomes from large clinical trials.
- **Clinical Data:** [EGAD00001008548](https://ega-archive.org/dacs/EGAC00001002120) (includes treatment arm, histology, overall survival, progression-free survival, TLS-LA calls, and best confirmed overall response)
- **Processed Data:**
  - [EGAD00001007703](https://ega-archive.org/dacs/EGAC00001002120): Full tumor transcriptomes from 891 advanced NSCLC tumors.
  - [EGAD00001008390](https://ega-archive.org/dacs/EGAC00001002120): Log2(TPM + 1) for 192 tumor samples from POPLAR.
  - [EGAD00001008630](https://ega-archive.org/dacs/EGAC00001002120): Counts for 192 tumor samples from POPLAR.
